Clinical Trials
55 trialsVemurafenib Combined With Whole Brain Radiation Therapy or Radiosurgery in Patients With BRAF Mutation-Positive Melanoma and Brain Metastases
Thomas Jefferson University
Stereotactic Body Radiation Therapy With REGN2810 and/or Ipilimumab Before Surgery in Treating Participants With Progressive Advanced or Oligometastatic Prostate Cancer
Thomas Jefferson University
OVERPASS
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Durvalumab (MEDI4736) and Radiosurgery (fSRT Vs. PULSAR) for the Treatment of Non-Small Cell Lung Cancer Brain Metastases
University of Texas Southwestern Medical Center
Immunotherapy Combined With Y-90 and SBRT for Colorectal Liver Metastases
University of Colorado, Denver
MRI-Guided Radiation Therapy for the Treatment of Early-Stage Kidney Cancer, the MRI-MARK Trial
M.D. Anderson Cancer Center
Evaluation of Low-dose Irinotecan and Cyberknife® SBRT to Treat Colorectal Cancer With Limited Liver Metastasis
Wake Forest University Health Sciences
SCION
University of British Columbia
Stereotactic Radiosurgery for Soft Tissue Sarcoma
The Cooper Health System
64Cu-DOTA Pembrolizumab for Imaging Metastatic Solid Tumors in Patients Receiving Stereotactic Body Radiation
City of Hope Medical Center
Re-irradiation With NBTXR3 in Combination With Pembrolizumab for the Treatment of Inoperable Locoregional Recurrent Head and Neck Squamous Cell Cancer
M.D. Anderson Cancer Center
ACTION
Weill Medical College of Cornell University
Y-90 Versus SBRT for Inoperable HCC
OHSU Knight Cancer Institute
Study of Stereotactic Radiosurgery to the Subventricular Zone in Malignant Gliomas
Northwell Health
STICk-IM-NSCLC
Duke University
Safety of Navoximod and NLG802 With Stereotactic Body Radiotherapy (SBRT) Treatment of Advanced Solid Tumors
University of Pittsburgh
CKPancreas
Centre Francois Baclesse, Luxembourg
SIGNAL During a COVID-19 Pandemic
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Stereotactic Radiation Therapy Before Surgery for the Treatment of Resectable Brain Metastases
Jonsson Comprehensive Cancer Center
Stereotactic Radiosurgery (SRS) for Multiple CNS Mets
The Cooper Health System
RAXSIA
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
Evaluation of the Immunological Effects of a Combined Treatment With Radiation and Cyclophosphamide in Metastasized Breast Cancer Patients
University Hospital, Ghent
SBRT as a Vaccination for Metastatic Melanoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Focal Radiation Therapy for the Treatment of Low or Intermediate-Risk Prostate Cancer
Jonsson Comprehensive Cancer Center
CIMER
Weill Medical College of Cornell University
Ixabepilone and SBRT For Metastatic Breast Cancer
University of Texas Southwestern Medical Center
RADBRI
University Health Network, Toronto
Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
Single Arm Trial of Preoperative Stereotactic Body Radiation Therapy (SBRT) for T3a or Gleason Grade Group 4 Prostate Cancer
H. Lee Moffitt Cancer Center and Research Institute
Pembrolizumab After Lung SBRT for Medically Inoperable Early Stage Non-small Cell Lung Cancer
Case Comprehensive Cancer Center
HER2-positive Breast Cancer With Brain Metastasis (GCC 1345)
University of Maryland, Baltimore
Voxel Based Diffusion Tensor Imaging in Predicting Response in Patients With Brain Metastases Undergoing Whole Brain Radiation Therapy or Stereotactic Radiosurgery
Albert Einstein College of Medicine
Study of Neoadjuvent Chemotherapy Followed by SBRT in Patients With Resectable and Borderline Resectable Pancreatic Cancer
Indiana University
Study of Immune Checkpoint Inhibition With Radiation Therapy in Unresectable, Non-metastatic Pancreatic Cancer
NYU Langone Health
A Study of SBRT in Combination With rhGM-CSF for Stage IV NSCLC Patients Who Failed in Second-line Chemotherapy
Wuhan University
Two Radiation Dose Schedules of SBRT to Lung Metastases < 5cm in Dimension
University of Kentucky
Randomized Trial Comparing Stereotactic Body Radiation Therapy to Microwave Ablation for the Treatment of Localized Hepatocellular Carcinoma
University of Michigan Rogel Cancer Center
STEREO
University of Louisville
MRI Adaptive Replanning Using ViewRay
University of Miami
NAGKC 12-01
University of California, San Francisco
Phase II Study of First-line SBRT in Patients With Non-Metastatic Unresectable Pancreatic Cancer
H. Lee Moffitt Cancer Center and Research Institute
Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer
Wake Forest University Health Sciences
A Pilot Study of SBRT With Adjuvant Pazopanib for Renal Cell Cancer
Case Comprehensive Cancer Center
SBRT + TACE for Primary Hepatocellular Carcinoma
University of Pittsburgh
Stereotactic Radiosurgery Followed by Wedge Resection in Treating Patients With Early Stage Peripheral Non-small Cell Lung Cancer
University of Southern California
Stereotactic Boost for Oropharyngeal Squamous Cell Carcinoma
Dana-Farber Cancer Institute
A Phase Ib Study of Stereotactic Body Radiotherapy (SBRT) Plus Sorafenib in Patients With Unresectable Hepatocellular Carcinoma (HCC)
Indiana University
TACE With or Without Radiation Therapy in Treating Patients With Stage A-C Liver Cancer
Case Comprehensive Cancer Center
Surgery and Whole Brain Radiotherapy (RT) Versus Whole Brain Radiotherapy (RT) and Radiosurgery for 1-3 Resectable Brain Metastases
Barretos Cancer Hospital
QOL-Stereotactic RadioSurgery, Temozolomide + Erlotinib-Rx of 1-3 Brain Metastases in NSCLC
Rutgers, The State University of New Jersey